Paolo Zamboni

A long-awaited study into Paolo Zamboni’s treatment yields disappointment for most sufferers—yet hope of relief for a few

Results from a key Canadian study into venoplasty for MS appear to have been prematurely released, leaving questions

Internal documents show why Canada has not kept its promise to accelerate contentious clinical trials for MS

Brad Wall: ‘It’s a good day in the province of Saskatchewan’

MS drugs get fast-tracked all the time. Why can’t a clinical trial get the same treatment?

Zamboni’s research almost certainly has to have been junk

Private member’s bill would see federal government fund clinical trials of controversial treatment

Experts and journalists are reading whatever they want into a new study examining CCSVI in MS patients

I see that Colleague Kingston is unsure why the federal Minister of Health is frustrated at media coverage of her ministry’s approach to the vein-centered Zamboni hypothesis about multiple sclerosis. One possible reason, I think, is that statements like those of Liberal health critic Kirsty Duncan are being repeated rather uncritically. Duncan told Kingston “They say we need evidence-based medicine but they are doing nothing to gather evidence.” Nothing? I wonder how else, but as “evidence-gathering”, one could possibly characterize the seven MS Society-funded preliminary studies Aglukkaq mentioned in her burst of finger-wagging at the media. These studies are designed to establish precisely what needs to be confirmed before the dream of a pan-Canadian trial of vein therapy for MS can appropriately be fulfilled: namely, whether there is any such thing at all as “chronic cerebrospinal venous insufficiency”, and whether it is really correlated with MS.

COSH: “There’s no unitary global Science Court where hypotheses can be hauled in for exoneration or hanging”

Colby Cosh on why Dr. Paolo Zamboni should be the next reality TV star

COSH on the troubles with Paolo Zamboni’s “liberation therapy”